Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 3 | 0 | €14.58 | €24.13 | 65.579% |
| Xencor Inc. | 14 | 1 | 4 | 0 | €18.00 | €31.70 | 76.092% |
| Esperion Therapeutis.Inc. | 14 | 1 | 0 | 1 | €2.04 | €9.27 | 355.666% |
| Corcept Therapeutics Inc. | 14 | 0 | 3 | 0 | €28.50 | €37.08 | 30.098% |
| Celldex Therapeutics | 15 | 1 | 4 | 0 | €33.80 | €58.01 | 71.629% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €39.20 | €46.08 | 17.557% |
| PTC Therapeutics Inc. | 15 | 9 | 1 | 2 | €30.40 | €41.51 | 36.554% |
| Geron Corp. | 16 | 0 | 4 | 0 | €4.28 | €5.57 | 30.126% |
| Intellia Therapeutics Inc | 17 | 1 | 4 | 0 | €23.28 | €60.53 | 160.028% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.80 | €26.01 | 25.031% |
| Abbott Laboratories | 18 | 0 | 1 | 0 | €98.06 | €116.48 | 18.785% |
| Pacira Pharmaceuticals | 18 | 0 | 0 | 0 | €26.20 | €47.53 | 81.405% |
| Krystal Biotech | 18 | 0 | 1 | 0 | €166.00 | €180.00 | 8.434% |
| Arrowhead Pharmaceuticals Inc. | 18 | 2 | 4 | 0 | €25.38 | €54.74 | 115.697% |
| Halozyme Therapeutics Inc. | 19 | 0 | 4 | 0 | €48.50 | €52.00 | 7.216% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €5.75 | - | - |
| G1 Therapeutics | 19 | 2 | 3 | 1 | €2.07 | €10.54 | 409.836% |
| EyePoint Pharmaceuticals Inc. | 20 | 1 | 2 | 0 | €8.10 | €27.83 | 243.423% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 0 | 0 | €78.30 | €102.62 | 31.059% |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 1 | 0 | €41.64 | €56.72 | 36.219% |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 6 | 0 | €36.80 | €85.51 | 132.368% |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | €17.14 | €28.06 | 63.737% |
| United Therapeutics | 22 | 0 | 3 | 0 | €297.10 | €289.92 | -2.417% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €160.08 | €200.06 | 24.973% |
| Amgen Inc. | 26 | 0 | 1 | 0 | €296.30 | €300.48 | 1.411% |